Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Hackensack, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Protalix BioTherapeutics, Inc. has filed 957 SEC EDGAR filings since 13 Aug 1996

SEC filing history

Showing 226-250 of 671 matching filings.

Per page
25
Current page
10
8-K File 001-33357

FORM 8-K

Filing date
01 Jun 2020
Reporting date
01 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
28 May 2020
Reporting date
27 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

8-K

Filing date
11 May 2020
Reporting date
11 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
11 May 2020
Reporting date
11 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-237736

EFFECT filing

Filing date
29 Apr 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-237736

424B3

Filing date
29 Apr 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
27 Apr 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
22 Apr 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-237736

FORM S-3

Filing date
17 Apr 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-33357

DEF 14A

Filing date
15 Apr 2020
Reporting date
07 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
13 Apr 2020
Reporting date
07 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-50118

SC 13G

Filing date
30 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-50118

SC 13G

Filing date
25 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-50118

PROTALIX BIOTHERAPEUTICS, INC.

Filing date
23 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
18 Mar 2020
Reporting date
18 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

8-K

Filing date
12 Mar 2020
Reporting date
12 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
12 Mar 2020
Reporting date
12 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-50118

AMENDED SCHEDULE 13G

Filing date
09 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-50118

AMENDMENT NO. 3 TO SCHEDULE 13G

Filing date
13 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-50118

AMENDMENT NO. 4 TO SCHEDULE 13G

Filing date
13 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
10 Feb 2020
Reporting date
10 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-50118

SC 13G/A

Filing date
07 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
06 Feb 2020
Reporting date
06 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
05 Feb 2020
Reporting date
03 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .